News Releases

October 25, 2018
DURHAM, NC – October 25, 2018 – Bioventus , a global leader in orthobiologic solutions, today announced the appointment of Susan M. Stalnecker, former Vice President and Treasurer, E.I. du Pont de Nemours and Company, to the company’s Board of Managers, replacing Michael Minogue.
July 23, 2018
DURHAM, NC – July 23, 2018 – Bioventus , a global leader in orthobiologic solutions, has entered into a definitive agreement to divest its next generation bone morphogenetic protein (BMP) development program to a new company formed by Viscogliosi Brothers, LLC (VB) , a private equity investment
March 5, 2018
DURHAM, NC – March 5, 2018 – Bioventus , a global leader in orthobiologic solutions, today launched DUROLANE , its single-injection, hyaluronic acid (HA) product used for joint lubrication in the treatment of pain associated with knee osteoarthritis (OA) .
February 26, 2018
DURHAM, NC – February 26, 2018 – Bioventus , a global leader in orthobiologic solutions, has entered into an agreement with LifeLink Tissue Bank, a division of LifeLink Foundation, Inc. headquartered in Tampa, FL, to co-develop a next generation bone allograft solution for use in spine and trauma
February 12, 2018
DURHAM, NC – February 12, 2018 – Bioventus , a global leader in orthobiologic solutions, has entered into an extension of its agreement with Seikagaku Corporation to continue distributing SUPARTZ FX ™ , a five – injection, hyaluronic acid (HA) product used for joint lubrication in the treatment of
January 25, 2018
DURHAM, NC– January 25, 2018 – Bioventus , a global leader in orthobiologics, today has launched a new version of EXOGEN.com , the product website for its EXOGEN Ultrasound Bone Healing System . EXOGEN uses safe, effective low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural
Displaying 31 - 38 of 38